|
357 Kim C *, Kim H *, Sim WS *, Jung M, Hong J, Moon S, Park JH, Kim JJ, Kang M, Kwon S, Ban K, Park HJ #, Kim BS #. Spatiotemporal control of neutrophil fate to tune inflammation and repair for myocardial infarction therapy. Nature Communications 15, 8481 (2024)
|
|
356 Moon S *, Jung M *, Go S, Hong J, Sohn HS, Kim C, Kang M, Lee BJ, Kim J, Lim J, Kim BS. Engineered nanoparticles for enhanced antitumoral synergy between macrophages and T cells in the tumor microenvironment. Advanced Materials 2410340 (2024) 
|
|
355 Kim J *, Lee BJ *, Moon S *, Lee J #, Kim BS #, Jung K #, Seo H #, Chung Y #. Strategies to overcome hurdles in cancer immunotherapy. Biomaterials Research 28: 80 (2024) |
|
354 Koo S*, Sohn HS*, Kim TH*, Yang S, Jang SY, Ye S, Choi B, Kim SH, Park KS, Shin HM, Park OK, Kim C, Kang M, Soh M, Yoo J, Kim D, Lee N, Kim BS#, Jung Y#, Hyeon T#. Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model. Nature Nanotechnology 18: 1502-1514 (2023) 
|
|
353 Go S, Jung M, Lee S, Moon S, Hong J, Kim C, Chung Y, Kim BS. A personalized cancer nanovaccine that enhances T-cell responses and efficacy through dual Interactions with dendritic cells and T cells. Advanced Materials 2303979 (2023) 
|
|
352 Kuen DS*, Hong J*, Lee SY, Koh CH, Kim BS, Jung M, Kim YJ, Cho BS#, Kim BS#, Chung Y#. A personalized cancer vaccine that induces synergistic innate and adaptive immune responses. Advanced Materials 2303080 (2023) 
|
|
351 Moon S, Hong J, Go S, Kim BS. Immunomodulation for tissue repair and regeneration. Tissue Engineering and Regenerative Medicine 20, 389-409 (2023) |
|
350 Jung M, Kim H, Hwang JW, Choi Y, Kang M, Kim C, Hong J, Lee NK, Moon S, Chang JW, Choi SJ, Oh SY, Jang H, Na DL, Kim BS. Iron oxide nanoparticle-incorporated mesenchymal stem cells for Alzheimer’s disease treatment. Nano Letters 23(2):
|
|
349 Hong J, Jung M, Kim C, Kang M, Go S, Sohn H, Moon S, Kwon S, Song SY, Kim BS. Senescent cancer cell-derived nanovesicle as a personalized therapeutic cancer vaccine. Experimental & Molecular Medicine 55, 541-554 (2023)
|
|
348 Sohn HS, Choi JW, Jhun JY, Kwon SP, Jung M, Yong S, Na HS, Kim JH, Cho ML, Kim BS. Tolerogenic nanoparticles induce type II collagen-specific regulatory T cells and ameliorate osteoarthritis. Science Advances 8(47), eabo5284 (2022) 
|
|
347 Jung M, Lee S, Park S, Hong J, Kim C, Cho I, Sohn HS, Kim K, Park IW, Yoon S, Kwon S, Shin J, Lee D, Kang M, Go S, Moon S, Chung Y, Kim YS, Kim BS. A Therapeutic Nanovaccine that Generates Anti-Amyloid Antibodies and Amyloid-specific Regulatory T cells for Alzheimer’s Disease. Advanced Materials 2207719 (2022)
|
|
346 Kim C, Lee SG, Lim S, Jung M, Kwon SP, Hong J, Kang M, Sohn HS, Go S, Moon S, Kim JS, Kim BS.
A Senolytic-Eluting Coronary Stent for the Prevention of In-Stent Restenosis. ACS Biomaterials Science & Engineering 8(5): 1921-1929 (2022) 
|
|
345 Kim HY, Kwon S, Um W, Shin S, Kim CH, Park JH, Kim BS. Functional extracellular vesicles for regenerative medicine. Small 2106569 (2022) 
|
|
344 Jung M, Kang M, Kim BS, Hong J, Kim C, Koh CH, Choi G, Chung Y, Kim BS. Nanovesicle-mediated targeted delivery of immune checkpoint blockades to potentiate therapeutic efficacy and prevent side effects. Advanced Materials 2106516 (2022) 
|
|
343 Lim S, An SB, Jung M, Joshi HP, Kumar H, Kim C, Song SY, Lee JR, Kang M, Han IB, Kim BS. Local Delivery of Senolytic Drug Inhibits Intervertebral Disc Degeneration and Restores Intervertebral Disc Structure. Advanced Healthcare Materials 11(2): 2101483 (2022) 
|
|
342 Bang S, Tahk D, Choi YH, Lee S, Lim J, Lee SR, Kim BS, Kim HN, Hwang NS, Jeon NL. 3D Microphysiological System-Inspired Scalable Vascularized Tissue Constructs for Regenerative Medicine. Advanced Functional Materials 32: 2105475 (2022) |
